News PTC's Huntington study was positive. Why did its stock fall? In a potentially pivotal trial, PTC Therapeutics' therapy for Huntington's disease met its primary endpoint, but there are questions about the data.
News Can other countries entice US scientists hit by Trump cuts? The UK is said to be preparing a £50m scheme to attract top scientific talent from other countries, including US teams facing big funding cuts.
News Trump's budget would be "catastrophic" for federal R&D Trump's 2026 budget request envisages sweeping cuts to funding for the NIH and other federal agencies that will be a disaster, say science advocates.
News Trials set up filings for AZ's triple therapy in asthma AstraZeneca's three-drug inhaler Breztri has shown efficacy for uncontrolled asthma in a pair of trials that could extend its label beyond COPD.
News Backers submit plans for £1bn cancer district in London A planning application has been filed to invest £1bn in "the world's leading centre for cancer research and treatment" in a London borough.
News NIH is pulling the plug on foreign research grants A new policy from the NIH in the US will cut billions of dollars of funding for research organisations and hospitals outside the US.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.